Subscribe for great stories in your community!
Blue Bell’s Neos Therapeutics is starting to compete for a share of the $10 billion ADHD market with last week’s launch of its…
Neos Therapeutics of Blue Bell has a new ADHD drug that became available to prescribe this week, writes John George of the Philadelphia Business Journal…
Before we send you to this site, please subscribe to our daily newsletter.